Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Search results

Showing results for

Researchers are working with schools around the county to find 24,000 volunteers aged 16 to 18 years to take part in the Be on the TEAM (Teenagers Against Meningitis) trial, led by the Oxford Vaccine Group at the Oxford University's Paediatrics Department with funding and support from the National Institute for Health Research (NIHR).

Amy Davis (pictured with fiancé Matt Jenkins) was 18 when she fell ill with meningococcal B septicaemia in 2011. Amy received urgent medical treatment which saved her life. During a long recovery period it was clear that septicaemia had affected Amy’s arms and legs and she later had to have her left leg amputated below the knee. Amy has welcomed a University of Oxford study, supported by the NHS, to see whether giving a group B meningococcal (MenB) vaccine to teenagers could help protect all ages from the potentially fatal infection. Photo credit: Meningitis Research Foundation.

In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine.

Journal article

Reiné J. et al, (2026), Comput Biol Chem, 122

Maternal views on RSV vaccination in the UK's second season.

Journal article

O'Hagan S. et al, (2026), Lancet Infect Dis, 26, e209 - e211

Paediatric case of invasive group A streptococcal necrotising myositis: diagnostic challenges and lessons learned.

Journal article

Yusuf S. et al, (2026), Lancet Infect Dis, 26, e259 - e267

Securing the future of immunisation: ESCMID's vision.

Journal article

Ramasamy MN. et al, (2026), Clin Microbiol Infect, 32, 516 - 518

Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.

Journal article

Weight CM. et al, (2026), J Infect Dis

Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.

Journal article

Turan G. et al, (2026), Vaccines (Basel), 14

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

Journal article

Bijukchhe SM. et al, (2026), Lancet Infect Dis

Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.

Journal article

Hausdorff WP. et al, (2026), Vaccine, 75

13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults.

Journal article

Tembo G. et al, (2026), Vaccine, 75

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.

Journal article

Cheliotis KS. et al, (2026), Vaccine, 75

Advances in Alphavirus and Flavivirus Research II.

Journal article

Kim YC. and Reyes-Sandoval A., (2026), Viruses, 18

Severe necrotizing soft tissue infections (SENSEI) study: Protocol for a multi-centered audit.

Journal article

Yoshimura R. et al, (2026), JPRAS Open, 48, 331 - 336

The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.

Journal article

Liatsikos K. et al, (2026), Lancet Microbe, 7

The Epidemiology and Clinical Burden of Human Adenovirus Respiratory Infections Among Hospitalized Children Under 5 Years in Jordan.

Journal article

Abu-Helalah M. et al, (2026), Pediatr Infect Dis J, 45, 229 - 235

Controlled human pneumococcal infection in the Netherlands: Colonisation, antibody responses and the impact of viral co-infection.

Journal article

van Beek LF. et al, (2026), J Infect, 92

Securing the future of immunisation: ESCMID’s vision

Journal article

Ramasamy MN. et al, (2026), CMI Communications, 3, 105167 - 105167

MR-Pro-adrenomedullin (MR-proADM) and Host Immune Response Biomarkers Evaluation of procalcitonin-guided antibiotic duration in Children with Infection for Stratification of Effectiveness: the PRECISE Study

Journal article

Waldron C-A. et al, (2026), Efficacy and Mechanism Evaluation, 1 - 46

Pneumococcal colonisation and mucosal immunity in adults with asthma following experimental human challenge

Journal article

Reiné J. et al, (2026), BMJ Immunology, 1, e000012 - e000012

Maternal perspectives on the RSV vaccine (Abrysvo): a thematic analysis of survey findings from the first season of implementation in England and Scotland.

Journal article

O'Hagan S. et al, (2026), Arch Dis Child

Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UK.

Journal article

Kudowa E. et al, (2026), NPJ Vaccines

Load More

Similar stories